A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.

Type

Journal article

Journal

Br Med J (Clin Res Ed)

Publication Date

10/04/1982

Volume

284

Pages

1081 - 1084

Keywords

Adolescent, Adult, Child, Child, Preschool, Clinical Trials as Topic, Deferoxamine, Dose-Response Relationship, Drug, Humans, Life Expectancy, Random Allocation, Thalassemia